Chargement en cours...
Effects of the Histone Deacetylase Inhibitor ITF2357 in Autoinflammatory Syndromes
We explored the effects of the oral histone deacetylase (HDAC) inhibitor ITF2357 in patients with autoinflammatory syndrome. In this prospective open-label pilot study, eight patients were enrolled; one patient with tumor necrosis factor receptor–associated periodic syndrome (TRAPS), three patients...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
ScholarOne
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105134/ https://ncbi.nlm.nih.gov/pubmed/21274502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00039 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|